Cargando…

What is the future of illicit drug profiling in Switzerland? Condemned to disappear or forgotten treasure

Illicit drug profiling bears a long history. Developments in the field from mid‐90s have led to several international profiling programs. Several countries have put their efforts to develop and implement the routine use of illicit drug profiling in the investigation and prosecution of illicit drug‐r...

Descripción completa

Detalles Bibliográficos
Autores principales: Meola, Susanna, Esseiva, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293460/
https://www.ncbi.nlm.nih.gov/pubmed/34587372
http://dx.doi.org/10.1002/dta.3167
_version_ 1784749637410750464
author Meola, Susanna
Esseiva, Pierre
author_facet Meola, Susanna
Esseiva, Pierre
author_sort Meola, Susanna
collection PubMed
description Illicit drug profiling bears a long history. Developments in the field from mid‐90s have led to several international profiling programs. Several countries have put their efforts to develop and implement the routine use of illicit drug profiling in the investigation and prosecution of illicit drug‐related crimes. For more than 20 years, the School of Criminal Sciences (ESC) at the University of Lausanne has, through its illicit drug expertise laboratory, played a main role in promoting the use of illicit drug profiling. In Switzerland, there is no national illicit drug profiling practice and the ESC laboratory is the only one offering such service. However, only a limited number of Swiss jurisdictions send regularly all or part of their seized specimens for analysis to the ESC laboratory. Profiling results are furnished to investigators and prosecutors regardless if they have been requested or not and are stored in a database with limited contextual information with no further data treatment. In 2020, the interruption of a project intended to develop and implement an intercantonal database gathering traditional police data, forensic data (e.g., DNA, fingerprints, etc.), and physical and chemical links, to produce intelligence and support investigation, led to the fundamental question: Is illicit drug profiling in Switzerland condemned to disappear or is it a forgotten treasure, a neglected approach that deserves to be revalued? This paper reports the Swiss situation regarding illicit drug profiling practices and discusses some factors that are thought to impact its use in day‐to‐day work.
format Online
Article
Text
id pubmed-9293460
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92934602022-07-20 What is the future of illicit drug profiling in Switzerland? Condemned to disappear or forgotten treasure Meola, Susanna Esseiva, Pierre Drug Test Anal Special Issue ‐ Perspectives Illicit drug profiling bears a long history. Developments in the field from mid‐90s have led to several international profiling programs. Several countries have put their efforts to develop and implement the routine use of illicit drug profiling in the investigation and prosecution of illicit drug‐related crimes. For more than 20 years, the School of Criminal Sciences (ESC) at the University of Lausanne has, through its illicit drug expertise laboratory, played a main role in promoting the use of illicit drug profiling. In Switzerland, there is no national illicit drug profiling practice and the ESC laboratory is the only one offering such service. However, only a limited number of Swiss jurisdictions send regularly all or part of their seized specimens for analysis to the ESC laboratory. Profiling results are furnished to investigators and prosecutors regardless if they have been requested or not and are stored in a database with limited contextual information with no further data treatment. In 2020, the interruption of a project intended to develop and implement an intercantonal database gathering traditional police data, forensic data (e.g., DNA, fingerprints, etc.), and physical and chemical links, to produce intelligence and support investigation, led to the fundamental question: Is illicit drug profiling in Switzerland condemned to disappear or is it a forgotten treasure, a neglected approach that deserves to be revalued? This paper reports the Swiss situation regarding illicit drug profiling practices and discusses some factors that are thought to impact its use in day‐to‐day work. John Wiley and Sons Inc. 2021-10-10 2022-03 /pmc/articles/PMC9293460/ /pubmed/34587372 http://dx.doi.org/10.1002/dta.3167 Text en © 2021 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Special Issue ‐ Perspectives
Meola, Susanna
Esseiva, Pierre
What is the future of illicit drug profiling in Switzerland? Condemned to disappear or forgotten treasure
title What is the future of illicit drug profiling in Switzerland? Condemned to disappear or forgotten treasure
title_full What is the future of illicit drug profiling in Switzerland? Condemned to disappear or forgotten treasure
title_fullStr What is the future of illicit drug profiling in Switzerland? Condemned to disappear or forgotten treasure
title_full_unstemmed What is the future of illicit drug profiling in Switzerland? Condemned to disappear or forgotten treasure
title_short What is the future of illicit drug profiling in Switzerland? Condemned to disappear or forgotten treasure
title_sort what is the future of illicit drug profiling in switzerland? condemned to disappear or forgotten treasure
topic Special Issue ‐ Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293460/
https://www.ncbi.nlm.nih.gov/pubmed/34587372
http://dx.doi.org/10.1002/dta.3167
work_keys_str_mv AT meolasusanna whatisthefutureofillicitdrugprofilinginswitzerlandcondemnedtodisappearorforgottentreasure
AT esseivapierre whatisthefutureofillicitdrugprofilinginswitzerlandcondemnedtodisappearorforgottentreasure